Amgen commits $1 billion for North Carolina expansion, sets up state’s latest high-profile pharmaceutical project

An aerial view of the first of Amgen’s drug manufacturing plants in Holly Springs, North Carolina, which is nearing completion. (CoStar)
Global biopharmaceutical company expects to create 370 jobs with new plant in Holly Springs